ATE308337T1 - Hgf zur behandlung von akutem nierenversagen - Google Patents

Hgf zur behandlung von akutem nierenversagen

Info

Publication number
ATE308337T1
ATE308337T1 AT98907233T AT98907233T ATE308337T1 AT E308337 T1 ATE308337 T1 AT E308337T1 AT 98907233 T AT98907233 T AT 98907233T AT 98907233 T AT98907233 T AT 98907233T AT E308337 T1 ATE308337 T1 AT E308337T1
Authority
AT
Austria
Prior art keywords
hgf
treatment
kidney failure
acute kidney
administering
Prior art date
Application number
AT98907233T
Other languages
English (en)
Inventor
Ikue Mori
Konohana-Ku Chome
Tomokazu Nagano
Original Assignee
Nakamura Toshikazu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nakamura Toshikazu filed Critical Nakamura Toshikazu
Application granted granted Critical
Publication of ATE308337T1 publication Critical patent/ATE308337T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
AT98907233T 1997-03-15 1998-03-12 Hgf zur behandlung von akutem nierenversagen ATE308337T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8223597 1997-03-15
PCT/JP1998/001081 WO1998041227A1 (en) 1997-03-15 1998-03-12 Hgf for treating acute renal failure

Publications (1)

Publication Number Publication Date
ATE308337T1 true ATE308337T1 (de) 2005-11-15

Family

ID=13768753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907233T ATE308337T1 (de) 1997-03-15 1998-03-12 Hgf zur behandlung von akutem nierenversagen

Country Status (8)

Country Link
US (1) US6436388B2 (de)
EP (1) EP0979097B1 (de)
JP (2) JP4865936B2 (de)
AT (1) ATE308337T1 (de)
AU (1) AU6311498A (de)
DE (1) DE69832165T2 (de)
TW (1) TW527190B (de)
WO (1) WO1998041227A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869609B1 (en) * 1997-12-03 2005-03-22 Sumitomo Pharmaceuticals Co., Ltd. Method for treatment of renal failure and occlusive lesion of blood vessels by administration of hepatocyte growth factor
WO2000007615A1 (en) * 1998-08-05 2000-02-17 Sumitomo Pharmacueticals Co., Ltd. Preparations for the administration of hepatocyte growth factor
CA2398310C (en) * 2000-01-31 2015-11-24 Uwe Waldemar Rothenpieler Methods for treating kidney disorders with pax2
US7612046B2 (en) 2000-01-31 2009-11-03 Uwe Waldemar Rothenpieler Method for treating kidney disorders
US8617351B2 (en) 2002-07-09 2013-12-31 Applied Materials, Inc. Plasma reactor with minimal D.C. coils for cusp, solenoid and mirror fields for plasma uniformity and device damage reduction
US8048806B2 (en) 2000-03-17 2011-11-01 Applied Materials, Inc. Methods to avoid unstable plasma states during a process transition
EP1840575A1 (de) 2000-08-28 2007-10-03 Damavand Wound AB Kit zur Bestimmung von HGF
TWI283899B (en) * 2002-07-09 2007-07-11 Applied Materials Inc Capacitively coupled plasma reactor with magnetic plasma control
US7125835B2 (en) * 2002-10-10 2006-10-24 International Flavors & Fragrances Inc Encapsulated fragrance chemicals
US7658913B2 (en) * 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091180A (en) * 1987-11-20 1992-02-25 Administrators Of The Tulane Educational Fund Protection against rhabdomyolysis-induced nephrotoxicity
JPH03255096A (ja) 1990-03-01 1991-11-13 Toyobo Co Ltd 組換ラット肝実質細胞増殖因子
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
JP2750372B2 (ja) * 1990-06-19 1998-05-13 敏一 中村 賢疾患治療剤
US5360790A (en) * 1990-12-11 1994-11-01 The Regents Of The University Of Michigan Method and formulations for the therapy of acute renal failure
EP0661993B1 (de) * 1992-09-16 1997-05-07 Genentech, Inc. Schutz gegen leberschäden mit hgf
WO1997012629A1 (en) * 1995-10-05 1997-04-10 Genentech, Inc. Improved angiogenesis using hepatocyte growth factor
JP3255096B2 (ja) 1997-10-01 2002-02-12 株式会社ニコン 露光装置及び露光方法

Also Published As

Publication number Publication date
JP4865936B2 (ja) 2012-02-01
DE69832165D1 (de) 2005-12-08
AU6311498A (en) 1998-10-12
DE69832165T2 (de) 2006-04-20
US6436388B2 (en) 2002-08-20
JP2001516358A (ja) 2001-09-25
WO1998041227A1 (en) 1998-09-24
TW527190B (en) 2003-04-11
EP0979097B1 (de) 2005-11-02
EP0979097A1 (de) 2000-02-16
JP2010100664A (ja) 2010-05-06
US20010047079A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
DE69616333D1 (de) Thip zur behandlung von schlafstörungen
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE200863T1 (de) Indolinonverbindungen zur behandlung von krankheiten
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
ATE180967T1 (de) Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür
DE69832165D1 (de) Hgf zur behandlung von akutem nierenversagen
DK0946166T3 (da) Anvendelse af matrixmetalloproteinaseinhibitorer til fremme af sårheling
EP1098642A4 (de) Verfahren zur behandlung von zustanden moduliert durch lactosylceramiden
ATE493978T1 (de) Behandlung von autoimmunerkrankungen
EA199900124A2 (ru) Способ лечения сердечной недостаточности
DE69802918D1 (de) Vwf propeptide enthaltendes pharmazeutisches präparat
DE69929787D1 (de) Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps
ATE463242T1 (de) Behandlung von inkontinenz
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
EP1056458A4 (de) Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DE69103021D1 (de) Verfahren zur verminderung des reissens von laufendem garn.
DE69736180D1 (de) Behandlung von manischen erkrankungen
ATE149840T1 (de) Behandlung von leberkrebs
ATE26841T1 (de) Verbindungen zur behandlung von erhoehtem blutdruck.
ATE203162T1 (de) Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4- aza-5 alpha-androst-1-en-3-one
DE69917445D1 (de) Reinigung von carboxaldehyd
DE69623767D1 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties